They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Forward – Looking Statements Page 2 • This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures. Platform operating income mix percentage 2005Y* 2008Y* 2010Y* YTD 2013 Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 49.7 $ 48.2 Global Color, Additives and Inks 4.3 28.1 37.7 83.4 Designed Structures and Solutions - - - 21.4 Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 153.0 Performance Products and Solutions 75.7 31.3 54.0 41.8 Distribution 19.5 28.1 42.0 49.7 SunBelt Joint venture 91.9 28.6 18.9 - Corporate (51.5) (425.1) (27.7) (61.7) Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 182.8 Less: Corporate operating expense 51.5 425.1 27.7 61.7 Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 244.5 Specialty platform operating mix percentage 2% 34% 43% 63% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.

November 2, 2023 Great Place 2)

We offer a wide range of color concentrates for different polymer grades, from standard to engineering polymers, that fulfill the vertical burning (V-0; V-1; V-2) and horizontal burning (HB) tests. PERFORMANCE A growing number of consumers are looking into the sustainability of appliances not only from the angle of energy consumption but also in terms of materials used to manufacture them.

Three common ways this can be done are 1) in a way that creates a woven structure, 2) by placing the fiber fabric into a mold that is injected with resin, or 3) by pultrusion, where the fibers are pulled through resin and then shaped and cured in a heated die.

ETO / Gamma radiation) • Facilitated 510(k) submission with formulations registered under Device Master File MAF 1833 • Pre-tested raw materials to biocompatibility ISO10993, US and Eu Pharmacopeia, ICH-Q3D extractable metals • Enhanced stability with gamma stabilizing package • Minimized risk of change with change control beyond CAS number level • Ensured uninterrupted supply from multiple ISO 13485-2016 certified sites • MEVOPURTM ISO 6009 Standard / Customized Solutions KEY REQUIREMENTS WHY AVIENT?

(*) manufactured without intentionally added PFAS and without PTFE (1) refers to sulfone products only https://www.avient.com/products/polymer-additives/processing-enhancement-additives/colorant-chromatics-evoluscend-non-pfas-high-temperature-mold-release-additive Slide Number 1

DAS Certification Ltd Certificate Number: DAS 47648113/31/OU Rev: 001 Registration House, 22b Church Street, Rushden, Northamptonshire, NN10 9YT, UK Tel: +44 (0) 1933 381859 Email: enquiries@dascertification.co.uk Web: www.dascertification.co.uk mailto:enquiries@dascertification.co.uk http://www.dascertification.co.uk/

Certificate Number: 13132875 Certified Since: November 19, 2019 * Certificate Approval Date (Date Granted, Reduced, Extended, or Renewed): October 12, 2022 Current Certification Cycle Start Date: November 19, 2022 Current Certification Cycle Expiration Date: November 18, 2025 Rev: B This certification is subject to the organization maintaining its management system to the requirements of ISO 9001:2015 as well as the requirements of Platinum Registration, Inc.

Anything they developed would have to meet the international electrical standard IEC 60670-1, which says the materials used in the wall boxes have to pass a Glow Wire Flammability Index (GWFI) 850°C testing (IEC 60695-2-12) at the application thickness, and 960°C at 2mm. In addition to passing these tests, the material offered a number of other key advantages, including: All grades pass IEC 60695-2-12 Glow Wire Flammability Index (GWFI) at 960°

Goff worked for ConocoPhillips Corporation, an integrated energy company, where he held a number of senior leadership positions, most recently Senior Vice President Commercial from 2008 to 2010. Jellison has served as Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and consults with other private equity and investment management firms in the Medtech industry.